Vagal nerve stimulation beyond epilepsy
نویسندگان
چکیده
منابع مشابه
Vagal nerve stimulation for refractory epilepsy: a brief review
Vagus nerve stimulation (VNS) is an effective adjunctive treatment for patients with drugresistance epilepsy. Short and long-term VNS studies demonstrate a seizure-suppressing effect, with a more efficacy in long-term treatment. Precise mechanisms of VNS in attenuating seizure are not fully understood. Clarification of VNS mechanisms of action may improve its clinical efficacy, as it may provid...
متن کاملVagal nerve stimulation for pharmacoresistant epilepsy in children
Vagus nerve stimulation (VNS) is an adjunctive treatment for adult patients with pharmacoresistant epilepsy. Little is known about VNS therapy for children with epilepsy. This article will: (1) Review the contemporary medical literature related to VNS therapy in children with epilepsy, (2) describe the experience of VNS treatment in 153 children less than 18 years of age, in the University of C...
متن کاملEfficacy of Vagal Nerve Stimulation for Drug-Resistant Epilepsy: Is it the Stimulation or Medication?
BACKGROUND Vagus nerve stimulation (VNS) therapy has been widely recognized as an alternative for the treatment of drug-resistant epilepsy, although modification of antiepileptic drugs (AEDs) during VNS treatment could explain the improvement in patients. METHODS We retrospectively assessed the efficacy of VNS in 30 adult patients with epilepsy treated with >6 months of follow-up. The criteri...
متن کاملVagal nerve stimulation—the Norwegian experience
The purpose of this open retrospective study was to analyze the efficacy and tolerability of vagal nerve stimulation (VNS) in a Norwegian cohort of referral patients with refractory epileptic seizures. A total of 47 patients have been assessed after a mean follow-up time of 2.7 years. Mean age was 34.4 years, mean duration of epilepsy was 25.3 years. Forty-two patients (89%) had localization-re...
متن کاملVagal nerve stimulation in heart failure.
It has been estimated that the prevalence of heart failure with a reduced ejection fraction exceeds 20 million patients worldwide— about 2% of the general population in the Western world—and that the annual incidence is . 2 million patients per year. The mortality of heart failure exceeds that of many malignancies. Significant healthcare improvements have been made with regard to pharmaceutical...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Developmental Medicine & Child Neurology
سال: 2018
ISSN: 0012-1622
DOI: 10.1111/dmcn.13779